Arrowstreet Capital, Limited Partnership Merck & Co., Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 6,473,094 shares of MRK stock, worth $568 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
6,473,094
Previous 6,959,133
6.98%
Holding current value
$568 Million
Previous $790 Million
18.52%
% of portfolio
0.53%
Previous 0.65%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,953Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.6 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.08 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.36 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $222B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...